Association between periodontitis and the risk of inadequate disease control in patients with rheumatoid arthritis under biological treatment

<jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>To assess the association between periodontitis (PD) and inadequate disease control (IDC) in patients with rheumatoid arthritis (RA) receiving biological therapy.</jats:p></jats:sec><jats:sec><jats:title>Materials and methods</jats:title><jats:p>In total, 111 RA patients receiving biological therapy for at least 3 months were assessed for periodontal disease at baseline. RA disease activity was assessed at baseline and at 3 months of follow‐up. A multivariable logistic regression analysis was used to estimate the association between PD and IDC, adjusting for age, sex, smoking, diabetes, and baseline RA disease activity. An additional exploratory model further controlled for disease characteristics and other medications.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among 111 patients, 84 (75.7%) had PD, of whom 37 (44.0%) received periodontal treatment. Thirty‐four (40.5%) of PD patients had IDC; 12 (32.4%) of treated PD patients and 22 (46.8%) of untreated patients had IDC, respectively. The ORs (95% CIs) for IDC were 1.45 (0.50–4.23) in PD patients and 1.84 (0.59–5.76) in untreated PD patients. In the exploratory model, the ORs (95% CIs) for IDC were 5.00 (1.19–21.03) in PD patients and 6.26 (1.34–29.34) in untreated PD patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>This single‐centre, prospective study failed to demonstrate a consistently positive correlation between PD and IDC in RA patients receiving biological treatment.</jats:p></jats:sec>